There is a trial of strength at the cellular level. Cells are in constant competition with each other and so eliminate ...

we successfully cloned and expanded the autologous P63+ progenitor cells from IPF patients to manufacture the cell therapeutic product REGEND001, which were further characterized by cell morphology ...

Rexlemestrocel-L for Chronic Low Back Pain associated with Degenerative Disc Disease - Phase 3 Program The confirmatory Phase 3 trial of Mesoblast's second generation allogeneic, STRO3-immunoselected, ...

National Engineering Research Center of Wheat and Corn Further Processing, School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, PR China School of Food ...

Imaging the molecules in the spindle of a dividing cell – a longstanding challenge at MBL and elsewhere -- is another example. "With traditional microscopy, including polarized light ...

Like other biological drugs, CAR-T cell products can trigger unwanted immune responses in patients receiving the treatment. This might lead to treatment failure or life-threatening consequences. This ...

Participants in the study, which enrolled from 2004 to 2009, were infused with two immune effector cell products -- activated T cells expanded with OKT3 antibody and Epstein-Barr virus (EBV ...

In its Q4 earnings call, William Fehrman, president and CEO of AEP, said: “Large load impacts are already being felt in ... Fehrman also briefly discussed the 100MW fuel supply agreement with fuel ...

Cardiovascular and Pulmonary Research Laboratory, Department of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado 80045, United States Cardiovascular and Pulmonary ...